{
  "url": "https://www.law.cornell.edu/regulations/new-york/N-Y-Comp-Codes-R--Regs-Tit-8-SS-66.6",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 8 ยง 66.6 - [Effective 8/7/2025] Continuing education for licensed optometrists certified to use phase one and/or phase two therapeutic pharmaceutical agents",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 8 ยง 66.6 - [Effective 8/7/2025] Continuing education for licensed optometrists certified to use phase one and/or phase two therapeutic pharmaceutical agents\n\nState Regulations\n(a) Definitions. As used in this section, acceptable accrediting agency means an\norganization accepted by the department as a reliable authority for the purpose\nof accreditation at the postsecondary level, applying its criteria for granting\naccreditation in a fair, consistent and nondiscriminatory manner, such as an\nagency recognized for this purpose by the United States Department of\n\nEducation. (b) Applicability of\nrequirements. (1)\n\nEach optometrist, required\nunder article 143 of the Education Law to register with the department to\npractice in New York State and certified to use topical therapeutic\npharmaceutical agents, therapeutic pharmaceutical agents, and/or oral\ntherapeutic pharmaceutical agents, shall comply with the mandatory continuing\neducation requirements as prescribed in subdivision (c) of this section, except\nthose licensees exempt from the requirement or who obtain an adjustment to the\nrequirement pursuant to paragraph (2) of this subdivision or who are subject to\na different requirement pursuant to this section. (2)\n\nExemptions and adjustments to the\nrequirement. (i) Exemptions. Licensed\noptometrists who are not engaged in the practice of optometry, as determined by\nthe department, shall be exempt from the continuing education requirements\nprescribed in subdivision (c) of this section, upon the filing of a statement\nwith the department declaring such status. Any such licensee who returns to the\npractice of optometry during the triennial registration period shall notify the\ndepartment prior to reentering the profession and shall meet the continuing\neducation requirements for the resumption of practice in New York State\nprescribed in subdivision (e) of this section. (ii)\n\nAdjustments to the requirement. An\nadjustment to the continuing education requirement, as prescribed in\nsubdivision (c) of this section, may be made by the department, provided that\nthe licensee documents good cause that prevents compliance or the department\ndetermines otherwise that there is good cause that prevents compliance, which\nshall include, but not be limited to, any of the following reasons: poor health\nor a specific physical or mental disability certified by an appropriate health\ncare professional; or extended active duty with the Armed Forces of the United\n\nStates; or other good cause beyond the licensee's control which in the judgment\nof the department, makes it impossible for the licensee to comply with the\ncontinuing education requirements in a timely\nmanner. (c) Mandatory continuing education requirements. (1)\n\nGeneral requirements. (i) During each triennial registration\nperiod, meaning a registration period of three years' duration, an optometrist\ncertified to use topical therapeutic pharmaceutical agents and/or therapeutic\npharmaceutical agents for the treatment of glaucoma and ocular hypertension, seeking to apply for registration shall complete at least 36 hours of\ncontinuing education, acceptable to the department, as prescribed in paragraph\n(3) of this subdivision. (ii)\n\nDuring each triennial registration period, meaning a registration period of\nthree years' duration, an optometrist certified to use oral therapeutic\npharmaceutical agents, seeking to apply for registration shall complete at\nleast 18 hours of additional continuing education, acceptable to the\ndepartment, as prescribed in paragraph (3) of this\nsubdivision. (2)\n\nProration. (i) Any licensed optometrist\ncertified to administer oral therapeutic pharmaceutical agents whose first\nregistration date following January 1, 2023 occurs less than three years from\nsuch date shall complete continuing education hours on a prorated basis at the\nrate of one and one-half hours of acceptable formal continuing education per\nmonth for the period beginning January 1, 2023 up to the first registration\ndate thereafter. Such continuing education shall be completed during the period\nbeginning January 1, 2023 and ending before the first day of the new\nregistration period. (ii)\n\nDuring\neach registration or certification period of less than three years duration, an\napplicant shall complete acceptable continuing education, as prescribed in\nparagraph (3) of this subdivision, on a prorated basis at the rate of one hour\nof continuing education per month for those certified to administer topical\ntherapeutic pharmaceutical agents and/or therapeutic pharmaceutical agents for\nthe treatment of glaucoma and ocular hypertension and, for those certified to\nadminister oral therapeutic pharmaceutical agents, on a prorated basis at the\nrate of one and one-half hour of continuing education per month for such\nregistration or certification period. (3)\n\nAcceptable formal continuing education. To be acceptable to the department, continuing education shall meet the\nrequirements of this paragraph. Such continuing education must be in subjects\nprescribed in subparagraph (i) of this paragraph and be the types of learning\nactivities prescribed in subparagraph (ii) of this paragraph and subject to the\nprohibition contained in subparagraph (iii) of this paragraph. (i) Subjects. (a) Acceptable continuing education of a\nlicensee certified to use topical therapeutic pharmaceutical agents and/or\ntherapeutic pharmaceutical agents for the treatment of glaucoma and ocular\nhypertension shall be in the area of ocular disease and pharmacology and may\ninclude both didactic and clinical components. (b) Acceptable continuing education of a\nlicensee certified to use oral therapeutic pharmaceutical agents shall be in\nthe area of systemic disease with ocular involvement and related therapeutic\ntreatments and may include both didactic and clinical\ncomponents. (ii)\n(a) Types of learning activities. Acceptable\ncontinuing education shall be the types of learning activities prescribed in\nthis subparagraph and shall be subject to the limitations prescribed in this\nsubparagraph and subparagraph (iii) of this paragraph. (b) Courses of learning. Acceptable\ncontinuing education shall be courses of learning offered by a sponsor approved\nby the department pursuant to subdivision (i) of this section. (1)\n\nFor optometrists certified for topical\ntherapeutic pharmaceutical agents and/or therapeutic pharmaceutical agents for\nthe treatment of glaucoma and ocular hypertension, at least 27 hours of\ncontinuing education in a registration period shall consist of live instruction\nin a formal course of study offered by a sponsor approved by the department\npursuant to subdivision (i) of this section, during which the student must be\nable to communicate and interact with the instructor and other students. Up to\nnine hours of such continuing education in a registration period may be\ncompleted through a self-study program, meaning structured study, provided by a\nsponsor approved pursuant to subdivision (i) of this section, that is based on\naudio, audio-visual, written, on-line, and other media, and does not include\nlive instruction, transmitted in person or otherwise, during which the student\nmay communicate and interact with the instructor and other students. (2)\n\nFor optometrists certified for oral\ntherapeutic pharmaceutical agents, in addition to meeting the continuing\neducation prescribed in subclause (1) of this clause, such optometrists shall\nalso complete at least 18 hours of such continuing education in a registration\nperiod shall consist of live instruction in a formal course of study offered by\na sponsor approved by the department pursuant to subdivision (i) of this\nsection, during which the student must be able to communicate and interact with\nthe instructor and other students. Up to nine hours of such continuing\neducation in a registration period may be completed through a self-study\nprogram, meaning structured study, provided by a sponsor approved pursuant to\nsubdivision (i) of this section, that is based on audio, audio-visual, written, on-line, and other media, and does not include live instruction, transmitted in\nperson or otherwise, during which the student may communicate and interact with\nthe instructor and other students. (iii)\n\nProhibition. Any continuing education\ndesigned for the sole purpose of personal development, marketing, business\npractices, and maximizing profits for the practice of a licensed optometrist\nshall not be considered as acceptable continuing education by the\ndepartment. (4)\n\nContinuing\neducation programs must be approved in advance by the department. Continuing\neducation programs shall be deemed approved if they are offered by a sponsor\nwho is approved pursuant to subdivision (i) of this section and meet the\nrequirements of acceptable continuing education pursuant to paragraph (3) of\nthis subdivision. (d) Renewal of certification. (1)\n\nAt each\nre-registration, licensed optometrists shall certify to the department that\nthey have either complied with the continuing education requirements, as\nprescribed in subdivision (c) of this section, or are subject to an exemption\nor adjustment to such continuing education requirements, as prescribed in\nsubdivision (b) of this section. (2)\nA licensee who has not satisfied the\nmandatory continuing education requirements shall not practice until such\nrequirements have been met and the licensee has been issued a registration\ncertificate by the department, except where a licensee has been issued a\nconditional registration, as provided for in subdivision (f) of this\nsection. (3)\n\nContinuing education\nhours taken during one registration period may not be transferred to the\nsubsequent registration period. (e) Requirement for lapse in practice. (1)\nA licensee returning to the practice of\noptometry after a lapse in practice, as evidenced by not being registered to\npractice in New York State, whose first registration date after such lapse in\npractice occurs less than three years from January 1, 2023 shall be required to\ncomplete: (i) at least one hour of acceptable\ncontinuing education for each month that the licensee was not registered to\npractice for a licensee certified to use topical therapeutic pharmaceutical\nagents and/or therapeutic pharmaceutical agents for the treatment of glaucoma\nand ocular hypertension or at least one and one-half hours of acceptable\ncontinuing education for each month that a licensee was not registered to\npractice for a licensee certified to use oral therapeutic pharmaceutical agents\nfrom January 1, 2023 until the beginning of the new registration period. (a) For a licensee who has not lawfully\npracticed optometry continuously in another jurisdiction throughout such lapse\nperiod, such continuing education shall be completed in the 12-month period\nbefore the beginning of the new registration period. (b) For a licensee who has lawfully practiced\nas a licensed optometrist continuously in another jurisdiction throughout such\nlapse period, such continuing education shall be completed in the new\nregistration period or, at the option of the licensee, in the period beginning\n36 months before the commencement of the new registration period and ending at\nthe conclusion of such new registration period; and\n(ii)\n(a) for a licensee who has not lawfully practiced as a licensed optometrist\ncontinuously in another jurisdiction throughout such lapse period, at least 12\nhours of acceptable continuing education in each successive 12-month period of\nthe new registration period for a licensee certified to use topical therapeutic\npharmaceutical agents and/or therapeutic pharmaceutical agents for the\ntreatment of glaucoma and ocular hypertension or at least 18 hours of\nacceptable continuing education for a licensee certified to use oral\ntherapeutic pharmaceutical agents; or\n(b) for a licensee who has lawfully practiced\noptometry continuously in another jurisdiction throughout such lapse period, the regular continuing education requirement described in subdivision (c) of\nthis section during the new registration period. (2)\n\nExcept as prescribed in paragraph (1) of\nthis subdivision for registrations therein specified, a licensee who returns to\npractice as a licensed optometrist after a lapse in practice in which the\nlicensee was not registered to practice in New York State and did not lawfully\npractice continuously in another jurisdiction throughout the lapse period, shall be required to complete: (i) the\ncontinuing education requirement applicable to the period of time the licensee\nwas registered in the licensee's last registration period; (ii)\nat least one hour of acceptable\ncontinuing education for each month of lapsed registration up to a maximum 36\nhours if certified to use topical therapeutic pharmaceutical agents and/or\ntherapeutic pharmaceutical agents for the treatment of glaucoma and ocular\nhypertension or a maximum of 54 hours if certified to use oral therapeutic\npharmaceutical agents. Such continuing education shall be completed in the 12\nmonths before the beginning of the new registration period; and\n(iii)\nat least 12 hours of acceptable\ncontinuing education in each succeeding 12-month period if certified to use\ntopical therapeutic pharmaceutical agents and/or therapeutic pharmaceutical\nagents for the treatment of glaucoma and ocular hypertension or 18 hours if\ncertified to use oral therapeutic pharmaceutical agents, after such\nregistration is reissued, until the next registration date. (3)\n\nExcept as prescribed in paragraph (1) of\nthis subdivision for registrations therein specified, a licensee who returns to\nthe practice of optometry after a lapse in practice in which the licensee was\nnot registered to practice in New York State but did lawfully practice\noptometry continuously in another jurisdiction throughout the lapse period, shall be required to complete: (i) the\ncontinuing education requirement applicable to the period of time the licensee\nwas registered in the licensee's last registration period; (ii)\nat least one hour of acceptable\ncontinuing education if certified to use topical therapeutic pharmaceutical\nagents and/or therapeutic pharmaceutical agents for the treatment of glaucoma\nand ocular hypertension and one-and-one-half hours if certified to use oral\ntherapeutic pharmaceutical agents for each month of lapsed registration up to a\nmaximum of 36 hours. Such continuing education shall be completed in the new\nregistration period or, at the option of the licensee, in the period beginning\n36 months before the commencement of the new registration period and ending at\nthe conclusion of the new registration period; and\n(iii)\nthe regular continuing education\nrequirement during the new registration period. (f) Conditional registration. (1)\n\nThe department may issue a conditional\nregistration to a licensee who attests to or admits to noncompliance with the\ncontinuing education requirements of this section, provided that such licensee\nmeets the following requirements: (i) the\nlicensee agrees to remedy such deficiency within the conditional registration\nperiod; (ii)\nthe licensee agrees to\ncomplete the regular continuing education requirement at the rate of one hour\nof acceptable continuing education per month during such conditional\nregistration period; and\n(iii)\nthe\nlicensee agrees to complete additional continuing education during such\nconditional registration period, which the department may require to ensure the\nlicensee's proper delivery of optometric services consistent with the\nlicensee's practice. (2)\n\nThe duration of such conditional registration shall not exceed one year and\nshall not be renewed or extended. (g) Licensee records. (1)\n\nEach licensee subject to the requirements\nof this section shall maintain a record of completed continuing education, which includes: the title of the course, the type of educational activity if an\neducational activity, the subject of the continuing education, the number of\nhours of continuing education completed, the sponsor's name and identifying\nnumber (if applicable), attendance verification, and the date and location of\nthe continuing education. The Department has the right to access the above\nrecords whether maintained by a sponsor or third party. (2)\n\nSuch records shall be retained for at\nleast six years from the date of completion of the continuing education and\nshall be made available for review by the department in the administration of\nthe requirements of this section. (h) Measurement of continuing education\nstudy. Continuing education credit shall be granted only for acceptable\ncontinuing education as prescribed in subdivision (c) of this section. For\ncontinuing education courses, a minimum of 50 minutes of study shall equal one\ncontinuing education hour of credit. For credit-bearing university or college\ncourses, each semester-hour of credit shall equal 15 continuing education hours\nof credit, and each quarter-hour of credit shall equal 10 continuing education\nhours of credit. (i) Sponsor\napproval. (1)\nA sponsor may only deliver a\ncontinuing education course if it is approved by the department under the\ncircumstances described in paragraph (2) or (3) of this subdivision. (2)\n\nSponsors of continuing education courses\nin the form of courses of learning or self-study programs shall be approved if\nthe sponsor submits an application to the department and is: (i) a post-secondary institution authorized\nto offer programs in optometry leading to licensure registered pursuant to Part\n52 of this Title or accredited by an acceptable accrediting agency; or\n(ii)\na national organization of\njurisdictional boards of optometry that promotes and protects the health, safety and welfare of the public and fosters good practice of optometry that\nhave standards for approving sponsors of continuing education that include, but\nare not limited to, standards that are equivalent to the standards prescribed\nin paragraph (3) of this subdivision. (3)\n\nDepartment review of sponsors. (i) All sponsors that do not meet the\ncriteria described in paragraph (2) of this subdivision must be reviewed by the\ndepartment prior to the delivery of continuing education to licensed\noptometrists. (ii)\n\nAn organization\ndesiring to offer continuing education based upon a department review under\nthis paragraph shall submit, with the fee as set forth in paragraph (j)(3) of\nthis section, an application for advance approval as a sponsor at least 90 days\nprior to the date of the commencement of such continuing education. In the\napplication, the organization must demonstrate that it: (a) will offer courses of learning or\nself-study programs in one or more of the subjects prescribed for acceptable\ncontinuing education in subparagraph (c)(3)(i) of this section; (b) has expertise in the professional areas\nthat will be taught; (c) provides\ncourse instructors who are qualified to teach the courses that will be offered, such as faculty of an optometry program offered by a higher education\ninstitution or instructors who are specially qualified authorities in the\nsubject area as determined by the department; (d) offers a method for assessing the\nlearning of participants; and\n(e) will maintain records for at least six years from the date of completion of\ncoursework, which shall include, but shall not be limited to, the name and\ncurriculum vitae of the faculty, a record of attendance of optometrists in the\ncourse if a course, a record of participation of optometrists in the\nself-instructional coursework if self-instructional coursework, an outline of\nthe course, date and location of the course, and the number of hours for\ncompletion of the course. (iii)\nA course that is approved by the\ndepartment pursuant to the requirements of this paragraph may be offered as\nlong as departmental approval is maintained by the sponsor. (iv)\n\nSponsors that are approved by the\ndepartment pursuant to the requirements of this paragraph shall be approved for\na three-year term. (v) The\ndepartment may conduct site visits of, or request information from, a sponsor\napproved pursuant to the requirements of this paragraph to ensure compliance\nwith such requirements. A sponsor shall cooperate with the department in\npermitting such site visits and in providing such information. (vi)\n\nIf the department determines that an\napproved sponsor is not meeting the standards set forth in this paragraph, the\ndepartment may revoke the sponsor's approved status. (vii)\n\nIf an approved sponsor discontinues\noperation, the governing body of such sponsor shall notify the department and\ntransfer continuing education records as directed by the department. (j) Fees\n(1)\n\nAt the beginning of each registration\nperiod, a mandatory continuing education fee of $45 shall be collected from\nlicensees engaged in the practice of optometry in New York State, except for\nthose exempt from the requirement pursuant to subparagraph (b)(2)(i) of this\nsection. This fee shall be in addition to any applicable registration fees\nrequired by section\n7104\nof the\n\nEducation Law. (2)\n\nLicensees\napplying for a conditional registration, pursuant to the requirements of\nsubdivision (f) of this section, shall pay a fee that is the same as, and in\naddition to, any applicable fee for the triennial registration required by\nsection\n7104\nof the\n\nEducation Law. In addition, such licensees shall pay the $45 mandatory\ncontinuing education fee. (3)\n\nOrganizations desiring to offer continuing education to licensed optometrists\nbased upon a department review, pursuant to paragraph (i)(3) of this section, shall submit an application fee of $900 with the application requesting the\nissuance of a permit from the department to become an approved sponsor of a\nformal continuing education program. A fee of $900 shall accompany an\napplication for a three-year renewal of the permit. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 8\nยง\n66.6\n\nAmended\n\nNew\n\nYork State Register June 3, 2015/Volume XXXVII, Issue 22, eff. 6/3/2015\n\nAmended\n\nNew\n\nYork State Register May 31, 2023/Volume XLV, Issue 22, eff. 5/31/2023\n\nAmended\n\nNew\n\nYork State Register June 25, 2025/Volume XLVII, Issue 25, eff. 6/9/2025, exp. 8/7/2025\n(Emergency)\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "unknown",
  "source_index": 36336
}